SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]
SEC Accession No. 0001193125-14-086855
Filing Date
2014-03-06
Accepted
2014-03-06 17:27:15
Documents
2
Filing Date Changed
2014-03-06

Document Format Files

Seq Description Document Type Size
1 FINAL PROSPECTUS SUPPLEMENT d685998d424b5.htm 424B5 407524
2 GRAPHIC g685998g42f52.jpg GRAPHIC 25681
  Complete submission text file 0001193125-14-086855.txt   444097
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-185856 | Film No.: 14674209
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1